Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Apotea AB (publ) | 119,091 | net | 04 Feb 2026 | tx 10+119,091 |
| Cint Group AB (publ) | 105,778 | net | 19 Feb 2021 | tx 2+106,473−695 |
| Eros Capital Partners AB | 14,500 | net | 06 Nov 2025 | tx 9+14,500 |
| Kinnevik AB (publ) | 4,000 | net | 14 Jul 2022 | tx 1+4,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 04 Feb 2026 | PURCHASE | Apotea AB (publ) | 911 | 59.72 SEK | |
| 04 Feb 2026 | PURCHASE | Apotea AB (publ) | 77 | 60.54 SEK | |
| 04 Feb 2026 | PURCHASE | Apotea AB (publ) | 493 | 59.77 SEK | |
| 04 Feb 2026 | PURCHASE | Apotea AB (publ) | 170 | 59.76 SEK | |
| 04 Feb 2026 | PURCHASE | Apotea AB (publ) | 116 | 59.75 SEK | |
| 04 Feb 2026 | PURCHASE | Apotea AB (publ) | 131 | 59.74 SEK | |
| 04 Feb 2026 | PURCHASE | Apotea AB (publ) | 175 | 59.73 SEK | |
| 04 Feb 2026 | PURCHASE | Apotea AB (publ) | 6,127 | 60.80 SEK | |
| 06 Nov 2025 | PURCHASE | Eros Capital Partners AB | 6,200 | 84.60 SEK | |
| 23 Sept 2025 | PURCHASE | Eros Capital Partners AB | 540 | 102.20 SEK | |
| 23 Sept 2025 | PURCHASE | Eros Capital Partners AB | 701 | 102.22 SEK | |
| 23 Sept 2025 | PURCHASE | Eros Capital Partners AB | 209 | 102.18 SEK | |
| 06 Dec 2024 | PURCHASE | Apotea AB (publ) | 510 | 58.00 SEK | |
| 05 Dec 2024 | PURCHASE | Apotea AB (publ) | 110,381 | 11.14 SEK | |
| 21 Nov 2024 | PURCHASE | Eros Capital Partners AB | 1,983 | 28.19 SEK | first after silence |
| 21 Nov 2024 | PURCHASE | Eros Capital Partners AB | 3,417 | 28.20 SEK | |
| 14 Jul 2022 | PURCHASE | Kinnevik AB (publ) | 4,000 | 165.31 SEK | first after silence |
| 19 Feb 2021 | PURCHASE | Cint Group AB (publ) | 106,473 | 72.00 SEK | anomaly |
| 19 Feb 2021 | SALE | Cint Group AB (publ) | 695 | 72.00 SEK |
2 purchases reported after at least 12 months of silence — most recent on 21 Nov 2024.